Search - tctmd.com

Displaying 141 - 160 of 379

Sort: Relevancy | Date

Presentation TCT 2020

TCT 238: One Year Clinical Outcomes of Ultrathin Biodegradable Polymer Coated Sirolimus Eluting Stents in Total Occlusion: A Multicentre, All-Comer Analysis

Presenter: Prakash Ajmera

October 14, 2020

Presentation TCT 2020

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

Presenter: Martin Hudec

October 14, 2020

Presentation TCT 2020

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

Presenter: Luca Testa

October 14, 2020

Presentation TCT 2020

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

Presenter: Alexandre Abizaid

October 14, 2020

Presentation TCT 2020

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

Presenter: A D S P K Athukorala

October 14, 2020

Presentation TCT 2020

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Presenter: Markus Krackhardt

October 14, 2020

Presentation TCT 2020

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

Presenter: Bernhard Witzenbichler

October 14, 2020

Presentation TCT 2020

TCT 255: Long Term Outcome After Coronary Revascularization With Sirolimus Coated Balloon in Patients With Small Vessel Disease (≤2.75mm): 3-Years Results From Nanolute Real-World Study

Presenter: Bernardo Cortese

October 14, 2020

Presentation TCT 2020

TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study

Presenter: Lukasz Koltowski

October 14, 2020

Presentation TCT 2020

TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes

Presenter: Matthias Lutz

October 14, 2020

News Industry News

Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels

September 02, 2020

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News

Drug-Coated Balloons for CAD: Some International Consensus

L.A. McKeown

May 27, 2020

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Todd Neale

March 31, 2020

News Conference News ACC 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Michael O'Riordan

March 30, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

L.A. McKeown

March 09, 2020

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

L.A. McKeown

February 25, 2020

Presentation

“Is Sirolimus the new concept for Drug Coated Balloon?”

Presenter: Bernardo Cortese

February 13, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Industry News

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

October 09, 2019

Advertisement

TCT 238: One Year Clinical Outcomes of Ultrathin Biodegradable Polymer Coated Sirolimus Eluting Stents in Total Occlusion: A Multicentre, All-Comer Analysis

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

TCT 255: Long Term Outcome After Coronary Revascularization With Sirolimus Coated Balloon in Patients With Small Vessel Disease (≤2.75mm): 3-Years Results From Nanolute Real-World Study

TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study

TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes

Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Drug-Coated Balloons for CAD: Some International Consensus

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

“Is Sirolimus the new concept for Drug Coated Balloon?”

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content